This may be a good re-entry point for CBIS. According to you, you made an excellent profit on your shares of CBIS before. CBIS is going to be EPIC when the positive results of their patient clinical trials are documented in medical journals. After this point CBIS will become the undisputed leader in medical marijuana research, treatment, and product development imo.
News 
Market Data 
Discover 
